About this episode
In this conversation, Professor S. Jay Olshansky discusses the evolution of aging science, the realistic limits of human life expectancy, and the concept of the Longevity Dividend, which emphasizes the health and economic benefits of modulating the aging process. He also explores the potential of biomarkers in predicting longevity, the societal implications of an aging population, and the ethical considerations surrounding advancements in longevity science.
Learn more about Professor S. Jay Olshansky:
http://sjayolshansky.com/sjo/Background.html
-
Download Dr. Buck Joffrey's FREE ebook, Living Longer for Busy People: https://ru01tne2.pages.infusionsoft.net/?affiliate=0
Book a FREE longevity coaching consultation with Dr. Buck Joffrey: https://coaching.longevityroadmap.com/
Get every episode summarized
Each time Longevity Roadmap publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Longevity Roadmap
169: Protein Folding Errors Contribute to Aging and Disease
Longevity Roadmap
168: Best of 2025
Longevity Roadmap
167: Why Bats Don't Age and Why You Should Care with Dr. Emma Teeling
Longevity Roadmap
166: BioXcellerator - The Cutting Edge of Stem Cell Therapy
Longevity Roadmap